CHART predicts XDC COIN Next BullRun & XDC Price Target
1 extracted signal · 0 resolved · 1 still active
Altcoin Doctor16 Jun 2026, 07:47 UTC
AI-generated source summary
The analysis focuses on the XDC/USDT cryptocurrency pair, indicating a bearish trend at the current price of $0.03065. The predicted trend is bullish, with a target price of $0.058. The failure bound, or invalidation level, is set at $0.0245. This suggests that if XDC/USDT falls below $0.0245, the bullish outlook would be invalidated. The analysis is based on technical indicators, specifically Fibonacci retracement levels applied from a previous high to a recent low. The timeframe for this analysis is daily (1D). The broader market context is also discussed using the BTC.D and TOTAL crypto market cap charts, suggesting that significant altcoin seasons and market cycles correlate with specific movements in Bitcoin dominance and overall market capitalization.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Source processing completed
Source analysis and structured extraction completed.
- Live evaluation in progress
1 signal remains active.
Signals in this source
More Prediction Case Files from Altcoin Doctor
SUI - THE EXPONENTIAL BLOCK - SUI Price Prediction
SOLANA - THE EXPONENTIAL BLOCK - SOLANA Price Prediction
RENDER - THE EXPONENTIAL BLOCK - RENDER Price Prediction
NEAR - THE EXPONENTIAL BLOCK - NEAR Price Prediction
AAVE - THE EXPONENTIAL BLOCK - AAVE Price Prediction
VECHAIN - THE EXPONENTIAL BLOCK - VET Price Prediction
Altcoin Doctor
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
